Search results for "Highlights"
SGLT-2 inhibitors associated with fewer serious renal events than DPP-4 inhibitors
In a propensity-matched Scandinavian study, new users of sodium-glucose cotransporter-2 (SGLT-2) inhibitors had a lower risk of renal replacement therapy and hospital admission for renal events than new users of dipeptidyl peptidase-4 (DPP-4) inhibitors.
https://diabetes.acponline.org/archives/2020/05/08/2.htm
8 May 2020
AHA issues statement on coronary artery disease management in patients with diabetes
The American Heart Association (AHA) addressed use of antithrombotics, hypertension drugs, and cholesterol therapies in patients with stable coronary artery disease and diabetes, among other recommendations.
https://diabetes.acponline.org/archives/2020/05/08/1.htm
8 May 2020
Diabetes-related variables, general comorbidities may predict major osteoporotic fractures
A study of African-American, Hispanic, and Caucasian patients with type 1 and type 2 diabetes found that the most significant predictors of fracture risk varied by race and ethnicity.
https://diabetes.acponline.org/archives/2020/04/10/2.htm
10 Apr 2020
Type 2 diabetes, elevated glucose associated with increased risk of unspecified dementia
Risk of Alzheimer's disease or vascular dementia was not associated with nonfasting plasma glucose levels in a large Danish study that included patients with and without diabetes.
https://diabetes.acponline.org/archives/2020/04/10/3.htm
10 Apr 2020
Sulfonylureas not supported as second-line treatment for type 2 diabetes
Risk for major adverse cardiovascular events and all-cause mortality was higher when a sulfonylurea was added to metformin compared to other typical second- or third-line therapy options in a recent Danish study.
https://diabetes.acponline.org/archives/2020/04/10/1.htm
10 Apr 2020
Diabetes associated with significantly increased risk of mortality in cardiomyopathy
Patients with diabetes and mild-to-moderate cardiomyopathy had higher mortality risk than nondiabetic patients with severe cardiomyopathy, suggesting that they may benefit from implantable cardioverter defibrillators, according to the study authors.
https://diabetes.acponline.org/archives/2020/03/13/2.htm
13 Mar 2020
Roux-en-Y gastric bypass associated with better long-term diabetes outcomes than sleeve gastrectomy
While both procedures were associated with high rates of type 2 diabetes remission, the rate of remission five years after surgery was about 10% higher in patients who had gastric bypass than in those who had sleeve gastrectomy.
https://diabetes.acponline.org/archives/2020/03/13/3.htm
13 Mar 2020
Glycemic control worse over time in type 2 patients who decline insulin, study finds
In adults with uncontrolled type 2 diabetes who initially declined insulin versus those who initially accepted, median time to an HbA1c level below 7.0% was 50 months versus 38 months.
https://diabetes.acponline.org/archives/2020/03/13/1.htm
13 Mar 2020
SGLT-2 inhibitors reduced risk of cardiovascular disease, death, review finds
The authors of a systematic review and meta-analysis recommended reconsideration of guidelines on sodium-glucose cotransporter-2 (SGLT-2) inhibitors to increase use among patients at risk of cardiovascular disease.
https://diabetes.acponline.org/archives/2020/02/14/3.htm
14 Feb 2020
HbA1c testing in barbershops identified black men with undiagnosed diabetes
About one-third of men approached in barbershops owned by black individuals were willing to be screened for diabetes, and 9% of them had undiagnosed diabetes while 28% had prediabetes.
https://diabetes.acponline.org/archives/2020/02/14/2.htm
14 Feb 2020